Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03042819
Title Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

sarcoma

Therapies

Doxorubicin + Selinexor

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.